HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 32, Issue 6, Pages 1087-1095
Publisher
Springer Nature
Online
2011-08-24
DOI
10.1007/s13277-011-0204-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
- (2010) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
- (2010) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women
- (2010) Emanuela Anastasi et al. TUMOR BIOLOGY
- HE4: a new potential early biomarker for the recurrence of ovarian cancer
- (2010) Emanuela Anastasi et al. TUMOR BIOLOGY
- Usefulness of serum HE4 in endometriotic cysts
- (2009) M Montagnana et al. BRITISH JOURNAL OF CANCER
- Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
- (2009) K Huhtinen et al. BRITISH JOURNAL OF CANCER
- Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system
- (2009) Edgar Petru et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Current state of biomarker development for clinical application in epithelial ovarian cancer
- (2009) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass
- (2009) Martina Montagnana et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology
- (2009) Rafael Molina et al. TUMOR BIOLOGY
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE
- (2008) Rafael Molina et al. TUMOR BIOLOGY
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now